ID   TPIS_HUMAN              Reviewed;         249 AA.
AC   P60174; B7Z5D8; D3DUS9; P00938; Q6FHP9; Q6IS07; Q8WWD0; Q96AG5;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   07-OCT-2020, sequence version 4.
DT   28-JAN-2026, entry version 210.
DE   RecName: Full=Triosephosphate isomerase {ECO:0000305|PubMed:18562316};
DE            Short=TIM;
DE            EC=5.3.1.1 {ECO:0000269|PubMed:18562316};
DE   AltName: Full=Methylglyoxal synthase {ECO:0000250|UniProtKB:P00939};
DE            EC=4.2.3.3 {ECO:0000250|UniProtKB:P00939};
DE   AltName: Full=Triose-phosphate isomerase;
GN   Name=TPI1 {ECO:0000312|HGNC:HGNC:12009}; Synonyms=TPI;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=2579079; DOI=10.1016/s0021-9258(19)83687-6;
RA   Maquat L.E., Chilcote R., Ryan P.M.;
RT   "Human triosephosphate isomerase cDNA and protein structure. Studies of
RT   triosephosphate isomerase deficiency in man.";
RL   J. Biol. Chem. 260:3748-3753(1985).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=4022011; DOI=10.1128/mcb.5.7.1694-1706.1985;
RA   Brown J.R., Daar I.O., Krug J.R., Maquat L.E.;
RT   "Characterization of the functional gene and several processed pseudogenes
RT   in the human triosephosphate isomerase gene family.";
RL   Mol. Cell. Biol. 5:1694-1706(1985).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8723724; DOI=10.1101/gr.6.4.314;
RA   Ansari-Lari M.A., Muzny D.M., Lu J., Lu F., Lilley C.E., Spanos S.,
RA   Malley T., Gibbs R.A.;
RT   "A gene-rich cluster between the CD4 and triosephosphate isomerase genes at
RT   human chromosome 12p13.";
RL   Genome Res. 6:314-326(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9074930; DOI=10.1101/gr.7.3.268;
RA   Ansari-Lari M.A., Shen Y., Muzny D.M., Lee W., Gibbs R.A.;
RT   "Large-scale sequencing in human chromosome 12p13: experimental and
RT   computational gene structure determination.";
RL   Genome Res. 7:268-280(1997).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Skeletal muscle;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M., Kovar-Smith C.,
RA   Lewis L.R., Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R.,
RA   Montgomery K.T., Morgan M.B., Nazareth L.V., Scott G., Sodergren E.,
RA   Song X.-Z., Steffen D., Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y.,
RA   Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G.,
RA   Chen Z., Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H.,
RA   Draper H., Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S.,
RA   Kelly S.H., Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M.,
RA   Nguyen B.-V., Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H.,
RA   Santibanez J., Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q.,
RA   Williams G.A., Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V.,
RA   Bailey M., Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E.,
RA   Burkett C.E., Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M., Dathorne S.R.,
RA   David R., Davis C.M., Davy-Carroll L., Deshazo D.R., Donlin J.E.,
RA   D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J., Escotto M., Flagg N.,
RA   Forbes L.D., Gabisi A.M., Garza M., Hamilton C., Henderson N.,
RA   Hernandez O., Hines S., Hogues M.E., Huang M., Idlebird D.G., Johnson R.,
RA   Jolivet A., Jones S., Kagan R., King L.M., Leal B., Lebow H., Lee S.,
RA   LeVan J.M., Lewis L.C., London P., Lorensuhewa L.M., Loulseged H.,
RA   Lovett D.A., Lucier A., Lucier R.L., Ma J., Madu R.C., Mapua P.,
RA   Martindale A.D., Martinez E., Massey E., Mawhiney S., Meador M.G.,
RA   Mendez S., Mercado C., Mercado I.C., Merritt C.E., Miner Z.L., Minja E.,
RA   Mitchell T., Mohabbat F., Mohabbat K., Montgomery B., Moore N., Morris S.,
RA   Munidasa M., Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O.,
RA   Nwokenkwo S., Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D., Trejos Z.Y.,
RA   Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I., Vera V.A.,
RA   Villasana D.M., Wang L., Ward-Moore S., Warren J.T., Wei X., White F.,
RA   Williamson A.L., Wleczyk R., Wooden H.S., Wooden S.H., Yen J., Yoon L.,
RA   Yoon V., Zorrilla S.E., Nelson D., Kucherlapati R., Weinstock G.,
RA   Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-5.
RX   PubMed=2925688; DOI=10.1016/s0021-9258(18)83716-4;
RA   Boyer T.G., Krug J.R., Maquat L.E.;
RT   "Transcriptional regulatory sequences of the housekeeping gene for human
RT   triosephosphate isomerase.";
RL   J. Biol. Chem. 264:5177-5187(1989).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain, Kidney, Placenta, Prostate, Skeletal muscle, Skin, and
RC   Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   PROTEIN SEQUENCE OF 2-249.
RX   PubMed=6434534; DOI=10.1016/s0021-9258(20)71304-9;
RA   Lu H.S., Yuan P.M., Gracy R.W.;
RT   "Primary structure of human triosephosphate isomerase.";
RL   J. Biol. Chem. 259:11958-11968(1984).
RN   [12]
RP   PROTEIN SEQUENCE OF 2-20.
RC   TISSUE=Mammary carcinoma;
RX   PubMed=9150946; DOI=10.1002/elps.1150180342;
RA   Rasmussen R.K., Ji H., Eddes J.S., Moritz R.L., Reid G.E., Simpson R.J.,
RA   Dorow D.S.;
RT   "Two-dimensional electrophoretic analysis of human breast carcinoma
RT   proteins: mapping of proteins that bind to the SH3 domain of mixed lineage
RT   kinase MLK2.";
RL   Electrophoresis 18:588-598(1997).
RN   [13]
RP   PROTEIN SEQUENCE OF 2-20.
RC   TISSUE=Colon carcinoma;
RX   PubMed=9150948; DOI=10.1002/elps.1150180344;
RA   Ji H., Reid G.E., Moritz R.L., Eddes J.S., Burgess A.W., Simpson R.J.;
RT   "A two-dimensional gel database of human colon carcinoma proteins.";
RL   Electrophoresis 18:605-613(1997).
RN   [14]
RP   PROTEIN SEQUENCE OF 6-14; 56-90; 60-131; 143-156; 161-175 AND 195-219, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Vishwanath V., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-21, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-21, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Pituitary;
RX   PubMed=16807684; DOI=10.1007/s11102-006-8916-x;
RA   Beranova-Giorgianni S., Zhao Y., Desiderio D.M., Giorgianni F.;
RT   "Phosphoproteomic analysis of the human pituitary.";
RL   Pituitary 9:109-120(2006).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-21, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17924679; DOI=10.1021/pr070152u;
RA   Yu L.R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
RT   "Improved titanium dioxide enrichment of phosphopeptides from HeLa cells
RT   and high confident phosphopeptide identification by cross-validation of
RT   MS/MS and MS/MS/MS spectra.";
RL   J. Proteome Res. 6:4150-4162(2007).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-21, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17693683; DOI=10.1074/mcp.m700120-mcp200;
RA   Tang L.-Y., Deng N., Wang L.-S., Dai J., Wang Z.-L., Jiang X.-S., Li S.-J.,
RA   Li L., Sheng Q.-H., Wu D.-Q., Li L., Zeng R.;
RT   "Quantitative phosphoproteome profiling of Wnt3a-mediated signaling
RT   network: indicating the involvement of ribonucleoside-diphosphate reductase
RT   M2 subunit phosphorylation at residue serine 20 in canonical Wnt signal
RT   transduction.";
RL   Mol. Cell. Proteomics 6:1952-1967(2007).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-21, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=T-cell;
RX   PubMed=19367720; DOI=10.1021/pr800500r;
RA   Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.;
RT   "Phosphorylation analysis of primary human T lymphocytes using sequential
RT   IMAC and titanium oxide enrichment.";
RL   J. Proteome Res. 7:5167-5176(2008).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-21, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-21 AND SER-80, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [23]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-14; LYS-194 AND LYS-238, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-21, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [25]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [26]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-21, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [27]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22905912; DOI=10.1021/pr300539b;
RA   Rosenow A., Noben J.P., Jocken J., Kallendrusch S., Fischer-Posovszky P.,
RA   Mariman E.C., Renes J.;
RT   "Resveratrol-induced changes of the human adipocyte secretion profile.";
RL   J. Proteome Res. 11:4733-4743(2012).
RN   [28]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-21; SER-80 AND SER-212, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [29]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-21; SER-212; THR-214 AND
RP   SER-223, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [30]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT LYS-194, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.o113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V., Aguiar M.,
RA   Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C., Vemulapalli V.,
RA   Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [31]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-142, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211; DOI=10.1073/pnas.1413825111;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [32]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [33]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 2-249 IN COMPLEX WITH SUBSTRATE
RP   ANALOG, HOMODIMERIZATION, ACTIVE SITE, AND SUBSTRATE BINDING-SITE.
RX   PubMed=8061610; DOI=10.1002/pro.5560030510;
RA   Mande S.C., Mainfroid V., Kalk K.H., Goraj K., Martial J.A., Hol W.G.J.;
RT   "Crystal structure of recombinant human triosephosphate isomerase at 2.8-A
RT   resolution. Triosephosphate isomerase-related human genetic disorders and
RT   comparison with the trypanosomal enzyme.";
RL   Protein Sci. 3:810-821(1994).
RN   [34]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 2-249.
RX   PubMed=16511037; DOI=10.1107/s1744309105008341;
RA   Kinoshita T., Maruki R., Warizaya M., Nakajima H., Nishimura S.;
RT   "Structure of a high-resolution crystal form of human triosephosphate
RT   isomerase: improvement of crystals using the gel-tube method.";
RL   Acta Crystallogr. F 61:346-349(2005).
RN   [35]
RP   X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF 39-289 OF MUTANT ASP-105,
RP   FUNCTION, SUBUNIT, CHARACTERIZATION OF VARIANT ASP-105, CATALYTIC ACTIVITY,
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND PATHWAY.
RX   PubMed=18562316; DOI=10.1074/jbc.m802145200;
RA   Rodriguez-Almazan C., Arreola R., Rodriguez-Larrea D., Aguirre-Lopez B.,
RA   de Gomez-Puyou M.T., Perez-Montfort R., Costas M., Gomez-Puyou A.,
RA   Torres-Larios A.;
RT   "Structural basis of human triosephosphate isomerase deficiency: mutation
RT   E104D is related to alterations of a conserved water network at the dimer
RT   interface.";
RL   J. Biol. Chem. 283:23254-23263(2008).
RN   [36]
RP   VARIANT TPID ASP-105.
RX   PubMed=2876430; DOI=10.1073/pnas.83.20.7903;
RA   Daar I.O., Artymiuk P.J., Phillips D.C., Maquat L.E.;
RT   "Human triose-phosphate isomerase deficiency: a single amino acid
RT   substitution results in a thermolabile enzyme.";
RL   Proc. Natl. Acad. Sci. U.S.A. 83:7903-7907(1986).
RN   [37]
RP   VARIANTS TPID ASP-105 AND MET-232.
RA   Neubauer B.A., Pekrun A., Eber S.W., Lakomek M., Schroeter W.;
RT   "Relation between genetic defect, altered protein structure, and enzyme
RT   function in triose-phosphate isomerase (TPI) deficiency.";
RL   Eur. J. Pediatr. Suppl. 151:232-232(1992).
RN   [38]
RP   VARIANT MANCHESTER ARG-123.
RX   PubMed=1339398; DOI=10.1007/bf02265287;
RA   Perry B.A., Mohrenweiser H.W.;
RT   "Human triosephosphate isomerase: substitution of Arg for Gly at position
RT   122 in a thermolabile electromorph variant, TPI-Manchester.";
RL   Hum. Genet. 88:634-638(1992).
RN   [39]
RP   VARIANT TPID HUNGARY LEU-241.
RX   PubMed=8503454;
RA   Chang M.-L., Artymiuk P.J., Wu X., Hollan S., Lammi A., Maquat L.E.;
RT   "Human triosephosphate isomerase deficiency resulting from mutation of Phe-
RT   240.";
RL   Am. J. Hum. Genet. 52:1260-1269(1993).
RN   [40]
RP   VARIANTS TPID ALA-73; ASP-105 AND MET-155.
RX   PubMed=8571957;
RA   Watanabe M., Zingg B.C., Mohrenweiser H.W.;
RT   "Molecular analysis of a series of alleles in humans with reduced activity
RT   at the triosephosphate isomerase locus.";
RL   Am. J. Hum. Genet. 58:308-316(1996).
RN   [41]
RP   VARIANTS TPID TYR-42; ASP-105 AND VAL-171.
RX   PubMed=9338582;
RX   DOI=10.1002/(sici)1098-1004(1997)10:4<290::aid-humu4>3.0.co;2-l;
RA   Arya R., Lalloz M.R.A., Bellingham A.J., Layton D.M.;
RT   "Evidence for founder effect of the Glu104Asp substitution and
RT   identification of new mutations in triosephosphate isomerase deficiency.";
RL   Hum. Mutat. 10:290-294(1997).
CC   -!- FUNCTION: Triosephosphate isomerase is an extremely efficient metabolic
CC       enzyme that catalyzes the interconversion between dihydroxyacetone
CC       phosphate (DHAP) and D-glyceraldehyde-3-phosphate (G3P) in glycolysis
CC       and gluconeogenesis. {ECO:0000269|PubMed:18562316}.
CC   -!- FUNCTION: It is also responsible for the non-negligible production of
CC       methylglyoxal a reactive cytotoxic side-product that modifies and can
CC       alter proteins, DNA and lipids. {ECO:0000250|UniProtKB:P00939}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=D-glyceraldehyde 3-phosphate = dihydroxyacetone phosphate;
CC         Xref=Rhea:RHEA:18585, ChEBI:CHEBI:57642, ChEBI:CHEBI:59776;
CC         EC=5.3.1.1; Evidence={ECO:0000269|PubMed:18562316};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:18586;
CC         Evidence={ECO:0000305|PubMed:18562316};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:18587;
CC         Evidence={ECO:0000305};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=dihydroxyacetone phosphate = methylglyoxal + phosphate;
CC         Xref=Rhea:RHEA:17937, ChEBI:CHEBI:17158, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:57642; EC=4.2.3.3;
CC         Evidence={ECO:0000250|UniProtKB:P00939};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.74 mM for D-glyceraldehyde 3-phosphate (at pH 7.4 and 25 degrees
CC         Celsius) {ECO:0000269|PubMed:18562316};
CC         Vmax=7.1 mmol/min/mg enzyme {ECO:0000269|PubMed:18562316};
CC   -!- PATHWAY: Carbohydrate degradation; glycolysis; D-glyceraldehyde 3-
CC       phosphate from glycerone phosphate: step 1/1. {ECO:0000255|PROSITE-
CC       ProRule:PRU10127}.
CC   -!- PATHWAY: Carbohydrate biosynthesis; gluconeogenesis.
CC       {ECO:0000255|PROSITE-ProRule:PRU10127}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000255|PROSITE-ProRule:PRU10127,
CC       ECO:0000269|PubMed:18562316, ECO:0000269|PubMed:8061610}.
CC   -!- INTERACTION:
CC       P60174; P42858: HTT; NbExp=6; IntAct=EBI-717475, EBI-466029;
CC       P60174; P12004: PCNA; NbExp=2; IntAct=EBI-717475, EBI-358311;
CC       P60174; P54274: TERF1; NbExp=2; IntAct=EBI-717475, EBI-710997;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|PROSITE-ProRule:PRU10127}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative promoter usage, Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P60174-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P60174-3; Sequence=VSP_060722;
CC       Name=3;
CC         IsoId=P60174-4; Sequence=VSP_060721;
CC   -!- DISEASE: Triosephosphate isomerase deficiency (TPID) [MIM:615512]: An
CC       autosomal recessive multisystem disorder characterized by congenital
CC       hemolytic anemia, progressive neuromuscular dysfunction, susceptibility
CC       to bacterial infection, and cardiomyopathy.
CC       {ECO:0000269|PubMed:2876430, ECO:0000269|PubMed:8503454,
CC       ECO:0000269|PubMed:8571957, ECO:0000269|PubMed:9338582,
CC       ECO:0000269|Ref.37}. Note=The disease is caused by variants affecting
CC       the gene represented in this entry.
CC   -!- MISCELLANEOUS: [Isoform 3]: Produced by alternative splicing.
CC       {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the triosephosphate isomerase family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH70129.1; Type=Miscellaneous discrepancy; Note=Sequence differs at the C-terminus.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Triosephosphate isomerase entry;
CC       URL="https://en.wikipedia.org/wiki/Triosephosphate_isomerase";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M10036; AAB59511.1; -; mRNA.
DR   EMBL; X69723; CAA49379.1; -; Genomic_DNA.
DR   EMBL; AK298809; BAH12874.1; -; mRNA.
DR   EMBL; U47924; AAB51316.1; -; Genomic_DNA.
DR   EMBL; CH471116; EAW88722.1; -; Genomic_DNA.
DR   EMBL; CH471116; EAW88723.1; -; Genomic_DNA.
DR   EMBL; J04603; AAN86636.1; -; Genomic_DNA.
DR   EMBL; BC007086; AAH07086.1; -; mRNA.
DR   EMBL; BC007812; AAH07812.1; -; mRNA.
DR   EMBL; BC009329; AAH09329.1; -; mRNA.
DR   EMBL; BC011611; AAH11611.1; -; mRNA.
DR   EMBL; BC015100; AAH15100.1; -; mRNA.
DR   EMBL; BC017165; AAH17165.1; -; mRNA.
DR   EMBL; BC017917; AAH17917.1; -; mRNA.
DR   EMBL; BC070129; AAH70129.1; ALT_SEQ; mRNA.
DR   EMBL; AK313282; BAG36090.1; -; mRNA.
DR   EMBL; CR541702; CAG46503.1; -; mRNA.
DR   CCDS; CCDS53740.1; -. [P60174-3]
DR   CCDS; CCDS58206.1; -. [P60174-4]
DR   CCDS; CCDS8566.1; -. [P60174-1]
DR   PIR; S29743; ISHUT.
DR   RefSeq; NP_000356.1; NM_000365.6. [P60174-1]
DR   RefSeq; NP_001152759.1; NM_001159287.1. [P60174-3]
DR   RefSeq; NP_001244955.1; NM_001258026.2. [P60174-4]
DR   PDB; 1HTI; X-ray; 2.80 A; A/B=2-249.
DR   PDB; 1KLG; X-ray; 2.40 A; C=23-37.
DR   PDB; 1KLU; X-ray; 1.93 A; C=23-37.
DR   PDB; 1WYI; X-ray; 2.20 A; A/B=2-249.
DR   PDB; 2IAM; X-ray; 2.80 A; P=23-37.
DR   PDB; 2IAN; X-ray; 2.80 A; C/H/M/R=23-37.
DR   PDB; 2JK2; X-ray; 1.70 A; A/B=2-249.
DR   PDB; 2VOM; X-ray; 1.85 A; A/B/C/D=2-249.
DR   PDB; 4BR1; X-ray; 1.90 A; A/B=4-249.
DR   PDB; 4E41; X-ray; 2.60 A; C/H=23-37.
DR   PDB; 4POC; X-ray; 1.60 A; A/B=1-249.
DR   PDB; 4POD; X-ray; 1.99 A; A/B=1-249.
DR   PDB; 4UNK; X-ray; 2.00 A; A/B=2-249.
DR   PDB; 4UNL; X-ray; 1.50 A; A/B=2-249.
DR   PDB; 4ZVJ; X-ray; 1.70 A; A/B=1-249.
DR   PDB; 6C2G; X-ray; 2.30 A; A/B/C/D=1-249.
DR   PDB; 6D43; X-ray; 2.04 A; A/B=4-249.
DR   PDB; 6NLH; X-ray; 2.20 A; A/B/C/D/E/F/G/H=5-249.
DR   PDB; 6UP1; X-ray; 1.83 A; A/B=1-249.
DR   PDB; 6UP5; X-ray; 1.92 A; A/B=1-249.
DR   PDB; 6UP8; X-ray; 2.00 A; A/B=1-249.
DR   PDB; 6UPF; X-ray; 1.65 A; A/B=1-249.
DR   PDB; 7RDE; X-ray; 1.31 A; A/B=1-249.
DR   PDB; 7SX1; X-ray; 2.23 A; A/B=1-249.
DR   PDB; 7T0Q; X-ray; 2.00 A; A/B=2-249.
DR   PDB; 7UXB; X-ray; 2.00 A; A/B=1-249.
DR   PDB; 7UXV; X-ray; 2.15 A; A/B=1-249.
DR   PDB; 9F69; X-ray; 1.17 A; A=5-249.
DR   PDB; 9FFC; X-ray; 1.25 A; A=1-249.
DR   PDBsum; 1HTI; -.
DR   PDBsum; 1KLG; -.
DR   PDBsum; 1KLU; -.
DR   PDBsum; 1WYI; -.
DR   PDBsum; 2IAM; -.
DR   PDBsum; 2IAN; -.
DR   PDBsum; 2JK2; -.
DR   PDBsum; 2VOM; -.
DR   PDBsum; 4BR1; -.
DR   PDBsum; 4E41; -.
DR   PDBsum; 4POC; -.
DR   PDBsum; 4POD; -.
DR   PDBsum; 4UNK; -.
DR   PDBsum; 4UNL; -.
DR   PDBsum; 4ZVJ; -.
DR   PDBsum; 6C2G; -.
DR   PDBsum; 6D43; -.
DR   PDBsum; 6NLH; -.
DR   PDBsum; 6UP1; -.
DR   PDBsum; 6UP5; -.
DR   PDBsum; 6UP8; -.
DR   PDBsum; 6UPF; -.
DR   PDBsum; 7RDE; -.
DR   PDBsum; 7SX1; -.
DR   PDBsum; 7T0Q; -.
DR   PDBsum; 7UXB; -.
DR   PDBsum; 7UXV; -.
DR   PDBsum; 9F69; -.
DR   PDBsum; 9FFC; -.
DR   AlphaFoldDB; P60174; -.
DR   SMR; P60174; -.
DR   BioGRID; 113020; 299.
DR   FunCoup; P60174; 1479.
DR   IntAct; P60174; 66.
DR   MINT; P60174; -.
DR   STRING; 9606.ENSP00000229270; -.
DR   BindingDB; P60174; -.
DR   ChEMBL; CHEMBL4880; -.
DR   DrugBank; DB04447; 1,4-Dithiothreitol.
DR   DrugBank; DB03379; 2-Carboxyethylphosphonic Acid.
DR   DrugBank; DB02726; 2-Phosphoglycolic Acid.
DR   DrugBank; DB03132; 3-(2-Benzothiazolylthio)-1-Propanesulfonic Acid.
DR   DrugBank; DB07387; 3-(BUTYLSULPHONYL)-PROPANOIC ACID.
DR   DrugBank; DB04510; 3-phospho-D-glyceric acid.
DR   DrugBank; DB03314; 5-fluorotryptophan.
DR   DrugBank; DB03135; [2(Formyl-Hydroxy-Amino)-Ethyl]-Phosphonic Acid.
DR   DrugBank; DB11638; Artenimol.
DR   DrugBank; DB04326; Dihydroxyacetone phosphate.
DR   DrugBank; DB01695; N-Hydroxy-4-phosphonobutanamide.
DR   DrugBank; DB03026; Phosphoglycolohydroxamic Acid.
DR   DrugBank; DB03900; tert-butanol.
DR   DrugBank; DB01593; Zinc.
DR   DrugBank; DB14487; Zinc acetate.
DR   DrugBank; DB14533; Zinc chloride.
DR   DrugBank; DB14548; Zinc sulfate, unspecified form.
DR   MoonProt; P60174; -.
DR   GlyGen; P60174; 1 site.
DR   iPTMnet; P60174; -.
DR   MetOSite; P60174; -.
DR   PhosphoSitePlus; P60174; -.
DR   SwissPalm; P60174; -.
DR   BioMuta; TPI1; -.
DR   DMDM; 353526311; -.
DR   REPRODUCTION-2DPAGE; IPI00797687; -.
DR   REPRODUCTION-2DPAGE; P60174; -.
DR   CPTAC; CPTAC-2780; -.
DR   jPOST; P60174; -.
DR   MassIVE; P60174; -.
DR   PaxDb; 9606-ENSP00000229270; -.
DR   PeptideAtlas; P60174; -.
DR   PRIDE; P60174; -.
DR   ProteomicsDB; 57186; -. [P60174-3]
DR   ProteomicsDB; 57187; -. [P60174-1]
DR   ProteomicsDB; 6680; -.
DR   Pumba; P60174; -.
DR   TopDownProteomics; P60174-1; -. [P60174-1]
DR   TopDownProteomics; P60174-3; -. [P60174-3]
DR   TopDownProteomics; P60174-4; -. [P60174-4]
DR   ABCD; P60174; 1 sequenced antibody.
DR   Antibodypedia; 22744; 474 antibodies from 37 providers.
DR   DNASU; 7167; -.
DR   Ensembl; ENST00000229270.8; ENSP00000229270.4; ENSG00000111669.16. [P60174-3]
DR   Ensembl; ENST00000396705.10; ENSP00000379933.4; ENSG00000111669.16. [P60174-1]
DR   Ensembl; ENST00000488464.6; ENSP00000475620.1; ENSG00000111669.16. [P60174-4]
DR   Ensembl; ENST00000535434.5; ENSP00000443599.1; ENSG00000111669.16. [P60174-4]
DR   Ensembl; ENST00000613953.4; ENSP00000484435.1; ENSG00000111669.16. [P60174-3]
DR   GeneID; 7167; -.
DR   KEGG; hsa:7167; -.
DR   MANE-Select; ENST00000396705.10; ENSP00000379933.4; NM_000365.6; NP_000356.1.
DR   UCSC; uc001qrk.5; human. [P60174-1]
DR   AGR; HGNC:12009; -.
DR   ClinPGx; PA36689; -.
DR   CTD; 7167; -.
DR   DisGeNET; 7167; -.
DR   GeneCards; TPI1; -.
DR   HGNC; HGNC:12009; TPI1.
DR   HPA; ENSG00000111669; Tissue enhanced (skeletal).
DR   MalaCards; TPI1; -.
DR   MIM; 190450; gene.
DR   MIM; 615512; phenotype.
DR   OpenTargets; ENSG00000111669; -.
DR   Orphanet; 868; Triose phosphate-isomerase deficiency.
DR   VEuPathDB; HostDB:ENSG00000111669; -.
DR   eggNOG; KOG1643; Eukaryota.
DR   GeneTree; ENSGT00390000013354; -.
DR   HOGENOM; CLU_024251_2_0_1; -.
DR   InParanoid; P60174; -.
DR   OrthoDB; 9472880at2759; -.
DR   PAN-GO; P60174; 6 GO annotations based on evolutionary models.
DR   PhylomeDB; P60174; -.
DR   BioCyc; MetaCyc:HS03441-MONOMER; -.
DR   BRENDA; 5.3.1.1; 2681.
DR   PathwayCommons; P60174; -.
DR   Reactome; R-HSA-70171; Glycolysis.
DR   Reactome; R-HSA-70263; Gluconeogenesis.
DR   SABIO-RK; P60174; -.
DR   SignaLink; P60174; -.
DR   SIGNOR; P60174; -.
DR   UniPathway; UPA00109; UER00189.
DR   UniPathway; UPA00138; -.
DR   Agora; ENSG00000111669; -.
DR   BioGRID-ORCS; 7167; 580 hits in 1183 CRISPR screens.
DR   CD-CODE; FB4E32DD; Presynaptic clusters and postsynaptic densities.
DR   ChiTaRS; TPI1; human.
DR   EvolutionaryTrace; P60174; -.
DR   GeneWiki; TPI1; -.
DR   GenomeRNAi; 7167; -.
DR   Pharos; P60174; Tbio.
DR   PRO; PR:P60174; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   RNAct; P60174; protein.
DR   Bgee; ENSG00000111669; Expressed in right frontal lobe and 211 other cell types or tissues.
DR   ExpressionAtlas; P60174; baseline and differential.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; HDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; HDA:UniProtKB.
DR   GO; GO:0008929; F:methylglyoxal synthase activity; ISS:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0004807; F:triose-phosphate isomerase activity; IDA:UniProtKB.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0061621; P:canonical glycolysis; IEA:Ensembl.
DR   GO; GO:0006094; P:gluconeogenesis; IBA:GO_Central.
DR   GO; GO:0046166; P:glyceraldehyde-3-phosphate biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0019563; P:glycerol catabolic process; IBA:GO_Central.
DR   GO; GO:0006096; P:glycolytic process; IBA:GO_Central.
DR   GO; GO:0019242; P:methylglyoxal biosynthetic process; ISS:UniProtKB.
DR   CDD; cd00311; TIM; 1.
DR   FunFam; 3.20.20.70:FF:000025; Triosephosphate isomerase; 1.
DR   Gene3D; 3.20.20.70; Aldolase class I; 1.
DR   HAMAP; MF_00147_B; TIM_B; 1.
DR   InterPro; IPR013785; Aldolase_TIM.
DR   InterPro; IPR035990; TIM_sf.
DR   InterPro; IPR022896; TrioseP_Isoase_bac/euk.
DR   InterPro; IPR000652; Triosephosphate_isomerase.
DR   InterPro; IPR020861; Triosephosphate_isomerase_AS.
DR   NCBIfam; TIGR00419; tim; 1.
DR   PANTHER; PTHR21139; TRIOSEPHOSPHATE ISOMERASE; 1.
DR   PANTHER; PTHR21139:SF2; TRIOSEPHOSPHATE ISOMERASE; 1.
DR   Pfam; PF00121; TIM; 1.
DR   SUPFAM; SSF51351; Triosephosphate isomerase (TIM); 1.
DR   PROSITE; PS00171; TIM_1; 1.
DR   PROSITE; PS51440; TIM_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative promoter usage;
KW   Alternative splicing; Cytoplasm; Direct protein sequencing;
KW   Disease variant; Gluconeogenesis; Glycolysis; Hereditary hemolytic anemia;
KW   Isomerase; Isopeptide bond; Lyase; Methylation; Nitration; Phosphoprotein;
KW   Proteomics identification; Reference proteome; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT   CHAIN           2..249
FT                   /note="Triosephosphate isomerase"
FT                   /id="PRO_0000090113"
FT   ACT_SITE        96
FT                   /note="Electrophile"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10127,
FT                   ECO:0000269|PubMed:8061610"
FT   ACT_SITE        166
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10127,
FT                   ECO:0000269|PubMed:8061610"
FT   BINDING         12
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10127,
FT                   ECO:0000269|PubMed:8061610"
FT   BINDING         14
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10127,
FT                   ECO:0000269|PubMed:8061610"
FT   MOD_RES         14
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         21
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:16807684,
FT                   ECO:0007744|PubMed:17081983, ECO:0007744|PubMed:17693683,
FT                   ECO:0007744|PubMed:17924679, ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:19367720, ECO:0007744|PubMed:19690332,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT   MOD_RES         68
FT                   /note="3'-nitrotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P17751"
FT   MOD_RES         80
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19690332,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         106
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P48500"
FT   MOD_RES         149
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P17751"
FT   MOD_RES         156
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P17751"
FT   MOD_RES         156
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P17751"
FT   MOD_RES         159
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P17751"
FT   MOD_RES         173
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P17751"
FT   MOD_RES         194
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         194
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   MOD_RES         194
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P17751"
FT   MOD_RES         198
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P48500"
FT   MOD_RES         209
FT                   /note="3'-nitrotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P17751"
FT   MOD_RES         212
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         214
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         223
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         238
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   CROSSLNK        142
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1)"
FT                   /evidence="ECO:0007744|PubMed:25114211"
FT   VAR_SEQ         1..82
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_060721"
FT   VAR_SEQ         1
FT                   /note="M -> MAEDGEEAEFHFAALYISGQWPRLRADTDLQRLGSSAM (in
FT                   isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_060722"
FT   VARIANT         42
FT                   /note="C -> Y (in TPID; dbSNP:rs121964848)"
FT                   /evidence="ECO:0000269|PubMed:9338582"
FT                   /id="VAR_007534"
FT   VARIANT         73
FT                   /note="G -> A (in TPID)"
FT                   /evidence="ECO:0000269|PubMed:8571957"
FT                   /id="VAR_007535"
FT   VARIANT         105
FT                   /note="E -> D (in TPID; no effect on triose-phosphate
FT                   isomerase activity; changed protein homodimerization
FT                   activity; the homodimer stability is temperature-dependent
FT                   and affects the triose-phosphate isomerase activity;
FT                   dbSNP:rs121964845)"
FT                   /evidence="ECO:0000269|PubMed:18562316,
FT                   ECO:0000269|PubMed:2876430, ECO:0000269|PubMed:8571957,
FT                   ECO:0000269|PubMed:9338582, ECO:0000269|Ref.37"
FT                   /id="VAR_007536"
FT   VARIANT         123
FT                   /note="G -> R (in Manchester; thermolabile;
FT                   dbSNP:rs121964846)"
FT                   /evidence="ECO:0000269|PubMed:1339398"
FT                   /id="VAR_007537"
FT   VARIANT         155
FT                   /note="V -> M (in TPID; dbSNP:rs188138723)"
FT                   /evidence="ECO:0000269|PubMed:8571957"
FT                   /id="VAR_007538"
FT   VARIANT         171
FT                   /note="I -> V (in TPID; dbSNP:rs121964849)"
FT                   /evidence="ECO:0000269|PubMed:9338582"
FT                   /id="VAR_007539"
FT   VARIANT         232
FT                   /note="V -> M (in TPID; dbSNP:rs1555132614)"
FT                   /evidence="ECO:0000269|Ref.37"
FT                   /id="VAR_007540"
FT   VARIANT         241
FT                   /note="F -> L (in TPID; Hungary; thermolabile;
FT                   dbSNP:rs121964847)"
FT                   /evidence="ECO:0000269|PubMed:8503454"
FT                   /id="VAR_007541"
FT   CONFLICT        20..21
FT                   /note="QS -> KN (in Ref. 11; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        27
FT                   /note="G -> S (in Ref. 11; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        30..31
FT                   /note="NA -> QG (in Ref. 11; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        43..44
FT                   /note="AP -> IG (in Ref. 11; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        58
FT                   /note="P -> Q (in Ref. 11; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        155
FT                   /note="V -> A (in Ref. 9; AAH17917)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        167
FT                   /note="P -> N (in Ref. 11; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        244
FT                   /note="I -> L (in Ref. 11; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   STRAND          7..12
FT                   /evidence="ECO:0007829|PDB:9F69"
FT   HELIX           19..31
FT                   /evidence="ECO:0007829|PDB:9F69"
FT   STRAND          38..43
FT                   /evidence="ECO:0007829|PDB:9F69"
FT   HELIX           46..48
FT                   /evidence="ECO:0007829|PDB:9F69"
FT   HELIX           49..55
FT                   /evidence="ECO:0007829|PDB:9F69"
FT   STRAND          60..65
FT                   /evidence="ECO:0007829|PDB:9F69"
FT   STRAND          69..72
FT                   /evidence="ECO:0007829|PDB:9F69"
FT   HELIX           81..86
FT                   /evidence="ECO:0007829|PDB:9F69"
FT   STRAND          91..95
FT                   /evidence="ECO:0007829|PDB:9F69"
FT   HELIX           97..101
FT                   /evidence="ECO:0007829|PDB:9F69"
FT   HELIX           107..119
FT                   /evidence="ECO:0007829|PDB:9F69"
FT   STRAND          123..128
FT                   /evidence="ECO:0007829|PDB:9F69"
FT   HELIX           132..136
FT                   /evidence="ECO:0007829|PDB:9F69"
FT   TURN            137..139
FT                   /evidence="ECO:0007829|PDB:6UP8"
FT   HELIX           140..152
FT                   /evidence="ECO:0007829|PDB:9F69"
FT   HELIX           158..160
FT                   /evidence="ECO:0007829|PDB:9F69"
FT   STRAND          161..165
FT                   /evidence="ECO:0007829|PDB:9F69"
FT   HELIX           168..170
FT                   /evidence="ECO:0007829|PDB:9F69"
FT   STRAND          171..174
FT                   /evidence="ECO:0007829|PDB:9F69"
FT   HELIX           179..196
FT                   /evidence="ECO:0007829|PDB:9F69"
FT   HELIX           199..204
FT                   /evidence="ECO:0007829|PDB:9F69"
FT   STRAND          207..209
FT                   /evidence="ECO:0007829|PDB:9F69"
FT   TURN            215..217
FT                   /evidence="ECO:0007829|PDB:9F69"
FT   HELIX           218..222
FT                   /evidence="ECO:0007829|PDB:9F69"
FT   STRAND          229..233
FT                   /evidence="ECO:0007829|PDB:9F69"
FT   HELIX           234..237
FT                   /evidence="ECO:0007829|PDB:9F69"
FT   HELIX           240..245
FT                   /evidence="ECO:0007829|PDB:9F69"
FT   TURN            246..248
FT                   /evidence="ECO:0007829|PDB:9F69"
SQ   SEQUENCE   249 AA;  26669 MW;  73844175635F858E CRC64;
     MAPSRKFFVG GNWKMNGRKQ SLGELIGTLN AAKVPADTEV VCAPPTAYID FARQKLDPKI
     AVAAQNCYKV TNGAFTGEIS PGMIKDCGAT WVVLGHSERR HVFGESDELI GQKVAHALAE
     GLGVIACIGE KLDEREAGIT EKVVFEQTKV IADNVKDWSK VVLAYEPVWA IGTGKTATPQ
     QAQEVHEKLR GWLKSNVSDA VAQSTRIIYG GSVTGATCKE LASQPDVDGF LVGGASLKPE
     FVDIINAKQ
//
